MedTrace Logo

Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

NCT00364702 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-08-17

No results posted yet for this study

Summary

Using a virtual reality program in screening and treatment of ADHD.

Conditions

  • ADHD

Interventions

DRUG

methylphenidate

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    lead OTHER

Principal Investigators

  • V. Gross, Prof/ md · Shaari Zedek Pediatric Neurology Unit

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
10 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2007-07-31
Completion
2007-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00364702 on ClinicalTrials.gov